IRIS

The benefit of cytoreductive nephrectomy (CNT) for cancer-specific mortality (CSM)-free survival is unclear in contemporary metastatic non-clear cell renal cell carcinoma (non-ccmRCC) patients.

Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study

Briganti, Alberto;
2019-01-01

Abstract

The benefit of cytoreductive nephrectomy (CNT) for cancer-specific mortality (CSM)-free survival is unclear in contemporary metastatic non-clear cell renal cell carcinoma (non-ccmRCC) patients.
2019
Inglese
Pubblicato
2-s2.0-85044969761
WOS:000486154800029
Cytoreductive nephrectomy; Kidney cancer; Metastatic cancer; Non-clear cell renal cell carcinoma; SEER database
none
12
info:eu-repo/semantics/article
262
Marchioni, Michele; Bandini, Marco; Preisser, Felix; Tian, Zhe; Kapoor, Anil; Cindolo, Luca; Primiceri, Giulia; Berardinelli, Francesco; Briganti, Alb...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/76040
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 49
social impact